Bausch Health and Roche Diagnostics Become the Latest Subscribers to the MedAccred Program

11 February 2020 The MedAccred program has grown to 10 Subscribers as Bausch Health and Roche Diagnostics join Baxter Healthcare, Bayer Healthcare, Becton Dickinson, Boston Scientific, Johnson & Johnson, Medtronic, Philips, and Stryker. With executives from each company actively participating in the MedAccred Management Council, they collaborate to provide leadership for the program through funding and setting strategic direction. Additionally, they support the operational activities of the MedAccred program by determining audit criteria for each critical process area, testing, interviewing, and selecting subject matter expert auditors, and making supplier MedAccred Accreditation decisions. The addition of Bausch Health and Roche Diagnostics brings the number of new MedAccred Subscribers to four for 2019. This rapid program growth illustrates the value that the medical device industry attributes to the MedAccred program and how this vital industry program contributes to enhanced quality and improved patient safety.